BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 14, 2009
 |  BC Week In Review  |  Company News  |  Other News

Karolinska Development dermatology, musculoskeletal news

Karolinska combined its portfolio companies DermaGen AB (Lund, Sweden), Lipopeptide AB (Stockholm, Sweden) and PharmaSurgics AB (Gothenburg, Sweden), into newco Pergamum AB. Karolinska also transferred its minority holdings in Omnio Healer AB (Umea, Sweden) and BioCis Pharma Ltd. (Turku, Finland) to Pergamum. Karolinska Development owns 64% of the newco, and the Foundation for Baltic and East European Studies...

Read the full 299 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >